Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Vascular Disease: early-phase trial registry
4 of 27 indexed Peripheral Vascular Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #598 of 28,707 conditions by registered trial count.
27 US clinical trials · 4 currently recruiting · #598 of 28,707 conditions by registered trial count
Peripheral Vascular Disease: 27 US clinical trials tracked, 4 recruiting.
Peripheral Vascular Disease is the subject of 27 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 4 of these trials.
Enrollment posture brief
Registry condition peripheral-vascular-disease
OPEN 4 | RECR 15% | LATE 2 | EARLY 8 | RANK #598 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Cerebrovascular Accident (15% recruiting · 27 trials)
Peripheral Vascular Disease lists 4 open slots (15% of 27 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Vascular Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Vascular Disease is recruiting below its size-band peers.
4 of 27 indexed trials (14.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Peripheral Vascular Disease trials is spread across many organizations.
Northwestern University accounts for 4 of 27 trials (14.8%). 22 distinct sponsors appear on at least one study for this condition label.
-
Typical Peripheral Vascular Disease enrolment sits around 148 participants.
Median target enrolment is 148 among the 26 trials that report a genuine target (sentinel values excluded). 11 of those (42.3%) plan for fewer than 100 participants.
-
Peripheral Vascular Disease research is mostly interventional.
25 interventional and 2 observational studies make up this index (92.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
27 total, page 1 of 1
Improving Mobility After Revascularization in Peripheral Artery Disease
Northwestern University
NCT06686121
Far Red Light to Improve Functioning in PAD
Northwestern University
NCT06165016
ENhancing Exercise with LIGHT to Improve Functioning in PAD
Northwestern University
NCT06399900
Leg Exercise Assistive Paddling (LEAP) Therapy for Peripheral Artery Disease
University of Nebraska
NCT06389149
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
BioGenCell
NCT02805023
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
University of Washington
NCT04281784
Femoral Arterial Access With Ultrasound Trial
University of California, Irvine
NCT00667381
Registry of AngioJet Use in the Peripheral Vascular System
Boston Scientific Corporation
NCT01086215
Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
Genzyme, a Sanofi Company
NCT00117650
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
Tanabe Pharma Corporation
NCT00059657
A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery
Terumo Medical Corporation
NCT01118117
Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System
Cordis US
NCT01355406
PF-00489791 For The Treatment Of Raynaud's
Pfizer
NCT01090492
BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease
C. R. Bard
NCT02655887
RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System
Abbott Medical Devices
NCT00736086
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
C. R. Bard
NCT02228564
Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
Valentis
NCT00113009
Absolute Pro® MOMENTUM™
Abbott Medical Devices
NCT01444378
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Horizons International Peripheral Group
NCT02464501
Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease
North Texas Veterans Healthcare System
NCT00827853
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Indiana University
NCT02685098
Guided Meditation to Decrease Perioperative Anxiety and Increase Patient Intraoperative Compliance in Vascular Surgery
Massachusetts General Hospital
NCT05837481
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
Midwest Cardiovascular Research Foundation
NCT01722877
Ischemic Preconditioning Claudication Study
Medical College of Wisconsin
NCT03511157
ALD-301 for Critical Limb Ischemia, Randomized Trial
Aldagen
NCT00392509
Stem Cell Injection for Peripheral Vascular Disease
Northwestern University
NCT00278603
Evaluation of the Effect of the Flowaid Device in Increasing Local Circulation in the Leg
Rosenblum, Jonathan I., DPM
NCT00538226
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 3 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Vascular Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Vascular Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Vascular Disease page
27 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Peripheral Vascular Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwestern University sponsors the most Peripheral Vascular Disease trials on record, review their full trial history before evaluating a specific study. See Northwestern University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Vascular Disease condition card totals 27 registered trials; most-linked intervention Sham light therapy; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.